Experience in using open-source automated insulin delivery systems in patients with type 1 diabetes mellitus
AbstractIn the Russian Federation, there is a rapid increase in the number of patients with type 1 diabetes mellitus (T1DM) who independently set up and use open-source closed loop automated insulin delivery (CL-AID) systems. In this regard, it seems important to evaluate the effectiveness and safety of CL-AID systems among patients with T1DM in Russia. Analysis of the results of the study showed that the use of CL-AID systems is associated with improvement in glycemic control and a reduction in the burden associated with hypoglycemia. The use of CL-AID systems leads to a significant decrease in HbA1c levels, increases time in range (TIR) and reduces glycemic variability in patients with T1DM. In patients on insulin therapy using the CL-AID systems there is a decrease in the level of fear of hypoglycemic conditions compared to multiple dose insulin injections therapy and to the method of continuous subcutaneous insulin infusion.
Keywords: type 1 diabetes mellitus; automated insulin delivery; closed loop system; glycemic control
Funding. The study had no sponsor support.
Conflict of interest. The authors declare no conflict of interest.
For citation: Nersesyan A.A., Chernaya M.E. Experience in using open-source automated insulin delivery systems in patients with type 1 diabetes mellitus. Endokrinologiya: novosti, mneniya, obuchenie [Endocrinology: News, Opinions, Training]. 2024; 13 (2): 77–80. DOI: https://doi.org/10.33029/2304-9529-2024-13-2-77-80 (in Russian)